24 February 2021

GSK Stockmann advises Wilhelm von Finck Group on participation in AVIAM

GSK Stockmann has comprehensively advised the Wilhelm von Finck Group (PE & Development) on the acquisition of 20% of the limited partnership shares in the project developer AVIAM, which specialises in care homes and residential real estate. The parties agreed to keep the purchase price confidential.

AVIAM Projektentwicklung AG & Co KGaA, based in Grünwald near Munich, arose out of the Bavarian residential developer Luxury M in 2019. Since then, the company’s deal volume has increased to approximately EUR 150 million. With the involvement of the Wilhelm von Finck Group as a strategic long-term investor from the region, it is planned to realise sustainable and, specifically, large-volume projects with a project volume of more than 100 million euros in the two business areas of care homes and residential real estate. This is intended to further expand the portfolio, which is currently still predominantly located in southern Germany.

Günter Koller, former founding partner of GSK Stockmann and managing director of the Wilhelm Finck Group, was appointed to AVIAM’s supervisory board.

GSK Stockmann provided comprehensive legal advice to the Wilhelm von Finck Group on the participation, in particular on the share purchase agreement and the joint venture agreement.

Dirk Brückner, who has been supporting the company for many years and most recently also advised on the further development of former Karstadt Sport in Neuhauser Straße in Munich, was the lead partner.

Advisers of Wilhelm von Finck Group:

GSK Stockmann: Dirk Brückner (lead, Real Estate); Marcel Vietor (Corporate), Dirk Koch (Tax); Associates: Katharina Feierabend (Real Estate), Yannik Stahl (Corporate), Stephan Wachsmuth (Tax), Martin Sturm (Public Law)

Print


Press contact
Christine Ström
+49 30 203907-7763
presse@gsk.de

Back

GSK Updates
  • 24 August 2021

    GSK Update: New marketing rules for investment management companies

    Read more
  • 23 June 2021

    GSK Update: The new German law on corporate due diligence in supply chains

    Read more
  • 21 June 2021

    GSK Update: Global data transfer: The new standard data protection clauses – What needs to be done?

    Read more
Contact person

Dr. Dirk Brückner

Partner*

+49 89 288174-0

dirk.brueckner@gsk.de

* Partner: A partner within the meaning of the partnership company law.
   Local Partner: not a partner within the meaning of the partnership company law.
CO2 Neutral